Introduction: This study aimed to elucidate the coagulation disorders in non-ICU patients with acute kidney injury (AKI) and their contribution to clotting-related outcomes of intermittent kidney replacement therapy (KRT). Methods: We included non-ICU-admitted patients with AKI requiring intermittent KRT, clinically having a risk of bleeding and against systemic anticoagulant use during KRT between April and December 2018. The premature termination of treatment due to circuit clotting was considered a poor outcome. We analyzed the characteristics of thromboelastography (TEG)-derived and traditional coagulation parameters and explored the potential-affecting factors. Results: In total, 64 patients were enrolled. Hypocoagulability was detected in 4.7%–15.6% of patients by a combination of the traditional parameters, i.e., prothrombin time (PT)/international normalized ratio, activated partial PT, and fibrinogen. No patient had hypocoagulability observed on TEG-derived reaction time; only 2.1%, 3.1%, and 10.9% of patients had hypocoagulability on TEG-derived kinetic time (K-time), α-angle, and maximum amplitude (MA), respectively, which were also platelet-related coagulation parameters, despite 37.5% of the cohort having thrombocytopenia. In contrast, hypercoagulability was more prevalent, involving 12.5%, 43.8%, 21.9%, and 48.4% of patients on TEG K-time, α-angle, MA, and coagulation index (CI), respectively, although thrombocytosis was only in 1.5% of the cohort. Patients with thrombocytopenia showed lower fibrinogen level (2.6 vs. 4.0 g/L, p = 0.00), α-angle (63.5° vs. 73.3°, p = 0.00), MA (53.5 vs. 66.1 mm, p = 0.00), and CI (1.8 vs. 3.6, p = 0.00) but higher thrombin time (17.8 vs. 16.2 s, p = 0.00) and K-time (2.0 vs. 1.2 min, p = 0.00) than those with a platelet count over 100 × 109/L. 41 patients were treated with heparin-free protocol, and 23 were treated with regional citrate anticoagulation (RCA). The premature termination rate was 41.5% on heparin-free patients, while 8.7% of patients underwent an RCA protocol (p = 0.006). Heparin-free protocol was the strongest adverse factor to poor outcomes. A heparin-free subgroup analysis found that the circuit clotting risk was increased by 61.7% with a 10 × 109/L elevation in platelet count (odds ratio [OR] = 1.617, p = 0.049) and decreased by 67.5% following a second increase of PT (OR = 0.325, p = 0.041). No significant correlation was found between TEG parameters and premature circuit clotting. Conclusions: Most non-ICU-admitted patients with AKI had normal-to-enhanced hemostasis and activated platelet function based on TEG results, as well as a high rate of premature circuit clotting when receiving heparin-free protocol despite thrombocytopenia. Further studies are needed to better determine the use of TEG in respect to management of anticoagulation and bleeding complications in AKI patients with KRT.

1.
Section 2: AKI definition
.
Kidney Int Suppl
.
2012
;
2
(
1
):
19
36
.
2.
Jubelirer
SJ
.
Hemostatic abnormalities in renal disease
.
Am J Kidney Dis
.
1985
;
5
(
5
):
219
25
.
3.
Campello
E
,
Zanetto
A
,
Radu
CM
,
Bulato
C
,
Truma
A
,
Spiezia
L
.
Acute kidney injury is associate d with increase d levels of circulating microvesicles in patients with decompensated cirrhosis
.
Dig Liver Dis
.
Jul 2021
53
7
879
88
.
4.
Perico
L
,
Benigni
A
,
Casiraghi
F
,
Ng
LFP
,
Renia
L
,
Remuzzi
G
.
Immunity, endothelial injury and complement-induced coagulopathy in COVID-19
.
Nat Rev Nephrol
.
2021
;
17
(
1
):
46
64
.
5.
Agarwal
B
,
Gatt
A
,
Riddell
A
,
Wright
G
,
Chowdary
P
,
Jalan
R
.
Hemostasis in patients with acute kidney injury secondary to acute liver failure
.
Kidney Int
.
2013
;
84
(
1
):
158
63
.
6.
Retter
A
,
Barrett
NA
.
The management of abnormal haemostasis in the ICU
.
Anaesthesia
.
2015
70
Suppl 1
121
7
, e40-1.
7.
Jansen
MPB
,
Florquin
S
,
Roelofs
J
.
The role of platelets in acute kidney injury
.
Nat Rev Nephrol
.
2018
;
14
(
7
):
457
71
.
8.
Hemostasis and thrombosis
.
Curr Opin Hematol
.
1994
1
5
B113
169
.
9.
Whiting
D
,
DiNardo
JA
.
TEG and ROTEM: technology and clinical applications
.
Am J Hematol
.
2014
;
89
(
2
):
228
32
.
10.
Hartert
H
.
Blutgerinnungstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren
.
Klin Wochenschr
.
1948
26
37–38
577
83
.
11.
Song
J
,
Zhang
W
,
Zhang
L
,
Yang
G
,
Zhang
J
,
Zhou
J
.
Consensus of Chinese experts on standardized evaluation of coagulation dysfunction in severe patients
.
PLAMJ
.
2022
;
47
(
2
):
107
17
.
12.
Subramanian
M
,
Kaplan
LJ
,
Cannon
JW
.
Thromboelastography-guided resuscitation of the trauma patient
.
JAMA Surg
.
2019
;
154
(
12
):
1152
3
.
13.
Shaydakov
ME
,
Sigmon
DF
,
Blebea
J
Thromboelastography. StatPearls. Treasure island (FL): StatPearls PublishingCopyright © 2022
StatPearls Publishing LLC
2022
.
14.
Wiedermann
CJ
,
Wiedermann
W
,
Joannidis
M
.
Hypoalbuminemia and acute kidney injury: a meta-analysis of observational clinical studies
.
Intensive Care Med
.
Oct 2010
36
10
1657
65
.
15.
Xia
M
,
Liu
D
,
Peng
L
,
Li
Y
,
Liu
H
,
Wu
L
.
Coagulation parameters are associated with the prognosis of immunoglobulin a nephropathy: a retrospective study
.
BMC Nephrol
.
2020
;
21
(
1
):
447
.
16.
Nascimento
B
,
Al Mahoos
M
,
Callum
J
,
Capone
A
,
Pacher
J
,
Tien
H
.
Vitamin K-dependent coagulation factor deficiency in trauma: a comparative analysis between international normalized ratio and thromboelastography
.
Transfusion
.
2012
;
52
(
1
):
7
13
.
17.
Dunham
CM
,
Rabel
C
,
Hileman
BM
,
Schiraldi
J
,
Chance
EA
,
Shima
MT
.
TEG and RapidTEG are unreliable for detecting warfarin-coagulopathy: a prospective cohort study
.
Thromb J
.
2014
;
12
(
1
):
4
.
18.
Westfall
K
,
Ramcharan
R
,
Shulkosky
M
,
Wahl
W
,
Hecht
J
.
The effect of antiplatelet agents on thromboelastography Critical Care Medicine
.
Jan
.
2022
;
50
(
1
):
311
.
19.
Hartmann
J
,
Mason
D
,
Achneck
H
.
Thromboelastography (TEG) point-of-care diagnostic for hemostasis management
.
Mar
.
2018
;
17
(
1
):
15
22
.
20.
Meier
K
,
Saenz
DM
,
Torres
GL
,
Cai
C
,
Rahbar
MH
,
McDonald
M
.
Thrombelastography suggests hypercoagulability in patients with renal dysfunction and intracerebral hemorrhage
.
J Stroke Cerebrovasc Dis
.
May 2018
27
5
1350
6
.
21.
Li
XH
,
Qian
YB
,
Meng
XX
,
Wang
RL
.
Effect of platelet-derived P-selectin on neutrophil recruitment in a mouse model of sepsis-induced acute kidney injury
.
Chin Med J
.
2017
;
130
(
14
):
1694
9
.
22.
Kim
SM
,
Kim
SI
,
Yu
G
,
Kim
JS
,
Hong
SI
,
Kim
WY
.
Hypercoagulability in septic shock patients with thrombocytopenia
.
J Intensive Care Med
.
Jun 2022
37
6
721
7
.
23.
Massaro
AM
,
Doerfler
S
,
Nawalinski
K
,
Michel
B
,
Driscoll
N
,
Ju
C
.
Thromboelastography defines late hypercoagulability after TBI: a pilot study
.
Neurocrit Care
.
2015
;
22
(
1
):
45
51
.
24.
Brown
W
,
Lunati
M
,
Maceroli
M
,
Ernst
A
,
Staley
C
,
Johnson
R
.
Ability of thromboelastography to detect hypercoagulability: a systematic review and meta-analysis
.
J Orthop Trauma
.
2020
;
34
(
6
):
278
86
.
25.
Kim
SM
,
Kim
SI
,
Yu
G
,
Kim
JS
,
Hong
SI
,
Kim
WY
.
Hypercoagulability in septic shock patients with thrombocytopenia
.
J Intensive Care Med
.
2022 Jun
37
6
721
7
.
26.
Gong
HY
,
Shi
C
,
Zhou
ZC
,
Teng
J
,
Sun
Y
,
Yang
C
.
Evaluating hypercoagulability in new-onset systemic lupus erythematosus patients using thromboelastography
.
J Clin Lab Anal
.
May 2020
34
5
e23157
.
27.
Lee
SH
,
Kim
HK
,
Ahn
JH
,
Kang
MG
,
Kim
KH
,
Bae
JS
.
Prognostic impact of hypercoagulability and impaired fibrinolysis in acute myocardial infarction
.
Eur Heart J
.
2023
ehad088
.
28.
Panigada
M
,
Bottino
N
,
Tagliabue
P
,
Grasselli
G
,
Novembrino
C
,
Chantarangkul
V
.
Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis
.
J Thromb Haemost
.
2020
;
18
(
7
):
1738
42
.
29.
Agarwal
B
,
Wright
G
,
Gatt
A
,
Riddell
A
,
Vemala
V
,
Mallett
S
.
Evaluation of coagulation abnormalities in acute liver failure
.
J Hepatol
.
2012
;
57
(
4
):
780
6
.
30.
Schoorl
M
,
Schoorl
M
,
Nube
MJ
,
Bartels
PCM
.
Platelet depletion, platelet activation and coagulation during treatment with hemodialysis
.
Scand J Clin Lab Invest
.
May 2011
71
3
240
7
.
31.
Vaisman
S
,
Kensey
K
,
Cho
YI
.
Effect of hemodialysis on whole blood viscosity
.
Int J Artif Organs
.
Jun 2009
32
6
329
35
.
32.
Wink
J
,
Vaziri
ND
,
Barker
S
,
Hyatt
J
,
Ritchie
C
.
The effect of hemodialysis on whole blood, plasma and erythrocyte viscosity
.
Int J Artif Organs
.
1988
;
11
(
5
):
340
2
.
33.
Marchioli
R
,
Finazzi
G
,
Specchia
G
,
Cacciola
R
,
Cavazzina
R
,
Cilloni
D
.
Cardiovascular events and intensity of treatment in polycythemia vera
.
N Engl J Med
.
2013
;
368
(
1
):
22
33
.
34.
Bettiol
A
,
Galora
S
,
Argento
FR
,
Fini
E
,
Emmi
G
,
Mattioli
I
.
Erythrocyte oxidative stress and thrombosis
.
Expert Rev Mol Med
.
Aug 2022
24
e31
.
35.
Ogasawara
N
,
Oguro
T
,
Sakabe
T
,
Matsushima
M
,
Takikawa
O
,
Isobe
K
.
Hemoglobin induces the expression of indoleamine 2,3-dioxygenase in dendritic cells through the activation of PI3K, PKC, and NF-kappaB and the generation of reactive oxygen species
.
J Cell Biochem
.
Oct 2009
108
3
716
25
.
36.
Yang
SH
,
Huang
XB
,
Liao
J
,
Li
Q
,
Chen
S
,
Liu
C
.
Platelet-leukocyte aggregates: a predictor for acute kidney injury after cardiac surgery
.
Jan
.
2021
;
43
(
1
):
1155
62
.
37.
Ambuhl
PM
,
Wuthrich
RP
,
Korte
W
,
Schmid
L
,
Krapf
R
.
Plasma hypercoagulability in haemodialysis patients: impact of dialysis and anticoagulation
.
Nephrol Dial Transplant
.
1997
;
12
(
11
):
2355
64
.
38.
Lopez
JA
,
Del Conde
I
,
Shrimpton
CN
.
Receptors, rafts, and microvesicles in thrombosis and inflammation
.
J Thromb Haemost
.
Aug 2005
3
8
1737
44
.
39.
Rubin
O
,
Delobel
J
,
Prudent
M
,
Lion
N
,
Kohl
K
,
Tucker
EI
.
Red blood cell-derived microparticles isolated from blood units initiate and propagate thrombin generation
.
Transfusion
.
2013
;
53
(
8
):
1744
54
.
40.
Robert
T
,
Bureau
C
,
Lebourg
L
,
Rondeau
E
,
Petitclerc
T
,
Ridel
C
.
A simple and novel technique for regional citrate anticoagulation during intermittent hemodialysis may obviate the need for calcium monitoring
.
Intensive Care Med
.
Dec 2017
43
12
1927
8
.
41.
Leroy
C
,
Pereira
B
,
Soum
E
,
Bachelier
C
,
Coupez
E
,
Calvet
L
.
Comparison between regional citrate anticoagulation and heparin for intermittent hemodialysis in ICU patients: a propensity score-matched cohort study
.
Ann Intensive Care
.
2021
;
11
(
1
):
13
.
42.
Tang
XY
,
Chen
DZ
,
Zhang
L
,
Fu
P
,
Chen
Y
,
Xiao
Z
.
Application of regional citrate anticoagulation in patients at high risk of bleeding during intermittent hemodialysis: a prospective multicenter randomized controlled trial
.
J Zhejiang Univ Sci B
.
2022
;
23
(
11
):
931
42
.
43.
Mehta
RL
,
McDonald
BR
,
Aguilar
MM
,
Ward
DM
.
Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients
.
Kidney Int
.
1990
;
38
(
5
):
976
81
.
44.
Oudemans-van Straaten
HM
.
Citrate for continuous renal replacement therapy: safer, better and cheaper
.
Crit Care
.
2014
;
18
(
6
):
661
.
45.
Shen
JI
,
Mitani
AA
,
Chang
TI
,
Winkelmayer
WC
.
Use and safety of heparin-free maintenance hemodialysis in the USA
.
Nephrol Dial Transplant
.
Jun 2013
28
6
1589
602
.
46.
Stucker
F
,
Ponte
B
,
Tataw
J
,
Martin
PY
,
Wozniak
H
,
Pugin
J
.
Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial
.
Crit Care
.
2015
;
19
(
1
):
91
.
47.
Skagerlind
MSE
,
Stegmayr
BG
.
An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis
.
Eur J Clin Pharmacol
.
2018
;
74
(
3
):
267
74
.
48.
Buturovic-Ponikvar
J
.
Is regional citrate anticoagulation the future of hemodialysis
.
Ther Apher Dial
.
Jun 2016
20
3
234
9
.
49.
Neal
MD
,
Moore
EE
,
Walsh
M
,
Thomas
S
,
Callcut
RA
,
Kornblith
LZ
.
A comparison between the TEG 6s and TEG 5000 analyzers to assess coagulation in trauma patients
.
J Trauma Acute Care Surg
.
2020
;
88
(
2
):
279
85
.
50.
Volod
O
,
Bunch
CM
,
Zackariya
N
,
Moore
EE
,
Moore
HB
,
Kwaan
HC
.
Viscoelastic hemostatic assays: a primer on legacy and new generation devices
.
J Clin Med
.
2022
;
11
(
3
):
860
.
You do not currently have access to this content.